Edition:
United Kingdom

Granules India Ltd (GRAN.NS)

GRAN.NS on National Stock Exchange of India

87.95INR
23 Aug 2019
Change (% chg)

Rs-0.60 (-0.68%)
Prev Close
Rs88.55
Open
Rs88.55
Day's High
Rs89.85
Day's Low
Rs87.00
Volume
379,713
Avg. Vol
589,932
52-wk High
Rs123.40
52-wk Low
Rs79.15

Latest Key Developments (Source: Significant Developments)

Granules India June Qtr Consol Profit Rises
Tuesday, 30 Jul 2019 

July 30 (Reuters) - Granules India Ltd ::JUNE QUARTER CONSOL PROFIT 832.4 MILLION RUPEES VERSUS 518 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 5.95 BILLION RUPEES VERSUS 4.53 BILLION RUPEES YEAR AGO.  Full Article

Granules India Gets USFDA Aaproval For Acetaminophen 650 MG, Extended Release Tablets
Thursday, 18 Apr 2019 

April 18 (Reuters) - Granules India Ltd ::SAYS GRANULES INDIA RECEIVED US FDA AAPROVAL FOR ACETAMINOPHEN 650 MG, EXTENDED RELEASE TABLETS.  Full Article

Granules India Says Promoters Sold Shares Worth 500 Mln Rupees In A Block Deal
Friday, 8 Mar 2019 

March 8 (Reuters) - Granules India Ltd ::SAYS PROMOTERS OF CO SOLD 5 MILLION SHARES TO GROUP OF INVESTORS IN A BLOCK DEAL.SAYS SHARE SALE FOR 500 MILLION RUPEES.SAYS PROMOTERS ARE ALSO MONETIZING PERSONAL ASSETS WORTH UP TO 500 MILLION RUPEES.SAYS FUNDS RAISED THROUGH THESE TRANSACTIONS WILL BE USED TO REDUCE PROMOTER LEVERAGE BY UP TO 1 BILLION RUPEES.SAYS POST DEALS, PROMOTERS PLEDGED POSITION WILL COME DOWN TO AROUND 30% FROM CURRENT LEVEL OF 54%.  Full Article

India's Granules India Sept-Qtr Consol Profit Rises
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Granules India Ltd ::SEPT QUARTER CONSOL PROFIT 602.6 MILLION RUPEES VERSUS PROFIT 403.3 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 5.81 BILLION RUPEES VERSUS 3.93 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 0.25 RUPEES PER SHARE.  Full Article

Granules India Unit Completes FDA Inspection With Two Form 483 Observations
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Granules India Ltd ::SAYS GRANULES PHARMACEUTICALS INC. COMPLETED U.S. FDA INSPECTION.SAYS INSPECTION COMPLETED WITH TWO FORM 483 OBSERVATIONS.  Full Article

India's Granules India June Qtr Consol Net Profit Rises
Monday, 23 Jul 2018 

July 23 (Reuters) - Granules India Ltd ::JUNE QUARTER CONSOL NET PROFIT 518.0 MILLION RUPEES VERSUS 368 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 4.53 BILLION RUPEES VERSUS 3.85 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 0.25 RUPEES PER SHARE.  Full Article

Granules India Gets EIR From U.S. FDA For Gagillapur Facility In Hyderabad
Friday, 1 Jun 2018 

June 1 (Reuters) - Granules India Ltd ::SAYS US FDA ISSUED EIR (ESTABLISHMENT INSPECTION REPORT) FOR CO'S GAGILLAPUR FACILITY IN HYDERABAD.SAYS NO 483 OBSERVATIONS GIVEN DURING INSPECTION BY FDA.  Full Article

Granules India March-Qtr Consol Profit More Than Halves
Thursday, 24 May 2018 

May 24 (Reuters) - Granules India Ltd ::MARCH QUARTER CONSOL NET PROFIT 204.4 MILLION RUPEES VERSUS PROFIT 456.7 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 5.04 BILLION RUPEES VERSUS 3.62 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 0.25 RUPEES PER SHARE.  Full Article

Granules India Gets EIR From U.S. FDA For Co's Jeedimetla Facility In Hyderabad
Wednesday, 16 May 2018 

May 16 (Reuters) - Granules India Ltd ::SAYS USFDA ISSUED ESTABLISHMENT INSPECTION REPORT FOR CO'S JEEDIMETLA FACILITY IN HYDERABAD.SAYS CO'S JEEDIMETLA FACILITY MANUFACTURES ACTIVE PHARMACEUTICAL INGREDIENTS AND PHARMACEUTICAL FORMULATION INTERMEDIATES.  Full Article

Granules India Gets ANDA Nod For Methocarbamol Tablet
Tuesday, 8 May 2018 

May 8 (Reuters) - Granules India Ltd ::SAYS CO GETS ANDA NOD FOR METHOCARBAMOL TABLET.SAYS CO EXPECTS TO COMMERCIALIZE PRODUCT SHORTLY.  Full Article